Blood Based Biomarker Market
- 2026 年市場規模
- USD 8.5 Bn
- 2033 年預估規模
- USD 16.5 Bn
- 年複合成長率 CAGR
- 7%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Blood Based Biomarker Market, By Type (Screening Biomarker, Diagnosis Biomarker, and Others), By Disease (Cancer, Neurological Disorders, and Others), By Application (Diagnostics, Drug Discovery, and Personalized Medicine), By Geography (North America, Latin America, Europe, Asia-Pacific, Middle East, and Africa)
報告摘要
The term biomarker, or biological marker, refers to a broad range of measures that capture what is happening in a cell or organism at a given moment. Blood-based biomarkers can be effective in formulating new diagnostic and treatment proposals. Blood-based biomarkers have significant advantages of being time and cost-efficient
Market Dynamics
Key players operating in the global blood based biomarker market are focusing on adoption of growth strategies such as product launch, collaboration, and fund raise which are expected to drive the market growth during the forecast period. For instance, in September 2020, ONCOtracker, Inc., a West Hollywood-based oncology company and The Binding Site Group Ltd, provides specialist diagnostic products to clinicians and laboratory professionals worldwide, announced they have entered into an exclusive global license and collaboration agreement to develop a novel clinical laboratory test for measuring sBCMA, a novel blood-based biomarker, which has shown promise to monitor and predict outcomes for patients with common blood-based cancers including multiple myeloma (MM) and chronic lymphocytic leukemia (CLL) and other related conditions. Moreover, for instance, in April 2021, Sera Prognostics, a Women’s health company had secured US$100 m in Series E financing to advance the commercialization of its PreTRM test for premature birth risk. The PreTRM test is a clinically validated and commercially available blood-based biomarker test, which offers an early, precise, and individualized risk prediction for spontaneous preterm birth in asymptomatic singleton pregnancies.
Key features of the study
• This report provides an in-depth analysis of the Global Blood Based Biomarker Market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2026-2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global blood based biomarker market based on the following parameters – Company Highlights, Products Portfolio, Key Highlights, Financial Performance, Strategies
• Key companies covered as a part of this study include Diadem srl., Proteomedix, Cleveland Diagnostics, F. Hoffmann-La Roche Ltd, GENFIT, Nutech Cancer Biomarkers India Pvt Ltd, SysmOex Corporation, Minomic, Creative Diagnostics, Eisai Co., Ltd., and C2N Diagnostics
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global blood based biomarker market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global blood based biomarker market
Market Segmentation
• By Type
o Screening Biomarker
o Diagnosis Biomarker
o Others
• By Disease
o Cancer
o Neurological Disorders
o Others
• By Application
o Diagnostics
o Drug Discovery
o Personalized Medicine
• By Region
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East & Africa
GCC Countries
Israel
Rest of Middle East & Africa
• Key Players
o Diadem srl.
o Proteomedix
o Cleveland Diagnostics
o Hoffmann-La Roche Ltd
o GENFIT
o Nutech Cancer Biomarkers India Pvt Ltd
o SysmOex Corporation
o Minomic, Creative Diagnostics, Eisai Co., Ltd.
o C2N Diagnostics
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snapshot, By Type
Market Snapshot, By Disease
Market Snapshot, By Application
Market Snapshot, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
Drivers
Restraints
Market Opportunities
o Impact Analysis
o Market Trends
o Key Developments
o Product Approval
o Collaboration/Merge/Acquisition
o Regulatory Landscape
o PEST Analysis
o Porter’s Five Forces Analysis
o Epidemiology
o Robust Pipeline Analysis
4. Blood Based Biomarkers Market, By Type, 2026 – 2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2026– 2033
Segment Trends
o Screening Biomarker
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (USD Bn)
o Diagnosis Biomarker
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (USD Bn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (USD Bn)
5. Blood Based Biomarkers Market, By Disease, 2026 – 2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2026 – 2033
Segment Trends
o Cancer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (USD Bn)
o Neurological Disorders
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (USD Bn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (USD Bn)
6. Blood Based Biomarkers Market, By Application, 2026 – 2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2026 – 2033
Segment Trends
o Diagnostics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (USD Bn)
o Drug Discovery
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (USD Bn)
o Personalized Medicine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (USD Bn)
7. Blood Based Biomarkers Market, By Region, 2026 – 2033, (USD Bn)
o Introduction
Market Share Analysis, By Region, 2026 and 2033 (%)
Y-o-Y Growth Analysis, For Regions, 2026–2033
Regional Trends
o North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Disease, 2026 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (USD Bn)
o U.S.
o Canada
o Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Disease, 2026 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (USD Bn)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Disease, 2026 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (USD Bn)
o U.K.
o Germany
o Italy
o France
o Spain
o Russia
o Rest of Europe
o Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Disease, 2026 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (USD Bn)
o China
o India
o Japan
o ASEAN
o Australia
o South Korea
o Rest of Asia Pacific
o Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Disease, 2026 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (USD Bn)
o GCC
o Israel
o Rest of Middle East
o Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Disease, 2026 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2026 – 2033, (USD Bn)
o North Africa
o Central Africa
o South Africa
8. Competitive Landscape
o Heat Map Analysis
o Market Share Analysis
o Company Profile
Diadem srl.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Proteomedix
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Cleveland Diagnostics
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
F. Hoffmann-La Roche Ltd
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
GENFIT
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Nutech Cancer Biomarkers India Pvt Ltd
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
SysmOex Corporation
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Minomic
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Creative Diagnostics
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Eisai Co., Ltd.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
C2N Diagnostics
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
o Analyst Views
9. Section
o References
o Research Methodology
o About Us
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們